Swiss Biotech Day 2022 in Basel: Simply great! May 9, 2022 May 2022- CROss Alliance® is very satisfied for the high interest on CROSS Research […] Read more
CROss Alliance® 2022 calendar has arrived! Jan 28, 2022 January 2022 – Every end of the year, since 2008, CROss Alliance® develops and […] Read more
CROss Alliance® becomes a Swiss Biotech Association (SBA) member Jan 11, 2022 January 2022 – CROss Alliance® is delighted to announce to have joined the Swiss […] Read more
Clinical phase completion of phase I trial with MAD0004J08 monoclonal antibody against SARS-CoV-2 Dec 20, 2021 December 2021 – CROss Alliance® is glad to announce the completion of the clinical […] Read more
GIQAR 2021 – The effect of Covid-19 pandemic on Quality Nov 11, 2021 October 2021 – CROss Alliance QA Unit attended the XXIX GIQAR meeting, sponsoring the […] Read more
CROss Alliance® successful outcome of Swissmedic GCP System Inspection Jul 27, 2021 July 2021 – As required by Federal Laws, CROSS activities are periodically subjected to […] Read more
Accelera and CROSS: an integrated solution for Pre-clinical to Clinical transition May 17, 2021 May 2021 – The relationship between Accelera and CROss Alliance® started a decade ago […] Read more
CROSS Research participation in phase 1 study with monoclonal antibody against SARS-COV2 Mar 9, 2021 March 2021 – CROss Alliance® is excited to share the news that on March […] Read more
Participation of CROss Alliance® in the Zurich Life Science Day 2021 Feb 11, 2021 February 2021 – On the 4th of February, Ursula Herranz, Business Development Unit Head […] Read more
Covid-19 – Phase I unit re-open Jun 23, 2020 June 2020 – We are relieved to announce that CROSS Research Phase I Unit […] Read more